Brief: Nautilus Biotechnology Inc Cash, Cash Equivalents, And Investments Were $275.7 Million As Of September 30, 2023
31/10/2023 12:09
Oct 31 (Reuters) - Nautilus Biotechnology Inc NAUT.O :
* NAUTILUS BIOTECHNOLOGY INC: CASH, CASH EQUIVALENTS, AND
INVESTMENTS WERE $275.7 MILLION AS OF SEPTEMBER 30, 2023
Source text for Eikon: ID:nGNX4KDDc1
Further company coverage: NAUT.O
Recent news on Nautilus Biotechnology
See all newsNautilus Biotechnology, Inc. expected to post a loss of 14 cents a share - Earnings Preview
Brief: Nautilus Biotechnology May Offer Up To $300 Million Of Securities - SEC Filing
Nautilus Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Nautilus Biotechnology posts first revenue, Q2 net loss narrows
Brief: Nautilus Biotechnology Q2 EPS USD -0.11